Drug Approval | July 14, 2024
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The facility is a part of Lupin Manufacturing Solutions
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
KIMS already have a multi-specialty hospital and gastro unit at Vizag
The Unit has been issued GMP Certification from ANVISA-Brazil
The approved ANDA is therapeutically equivalent to the reference listed drug product
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
